Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis

Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis

<p>Abstract</p> <p>Background</p> <p>Inhalational anesthetics have been shown to influence T cell functions both <it>in vitro</it> and <it>in vivo</it>, in many cases inducing T cell death, suggesting that exposure to these drugs could modify the...

Full description

Bibliographic Details
Main Authors:	Polak Paul E, Dull Randall O, Kalinin Sergey, Sharp Anthony J, Ripper Richard, Weinberg Guy, Schwartz David E, Rubinstein Israel, Feinstein Douglas L
Format:	Article
Language:	English
Published:	BMC 2012-12-01
Series:	Journal of Neuroinflammation
Subjects:	Myelin Experimental autoimmune encephalomyelitis Inhaled anesthetic Multiple sclerosis

Similar Items

The Role of MicroRNAs in Repair Processes in Multiple Sclerosis
by: Conor P. Duffy, et al.
Published: (2020-07-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

Association of New Putative Epitopes of Myelin Proteolipid Protein (58-74) with Pathogenesis of Multiple Sclerosis
by: Zahra Zamanzadeh, et al.
Published: (2016-10-01)

Effects of cigarette smoke exposure on a mouse model of multiple sclerosis
by: Jenny Ho, et al.
Published: (2022-01-01)

Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models
by: Zhixin Lei, et al.
Published: (2024-01-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
by: M. Moransard, et al.
Published: (2017-10-01)

The potential effects of hemp seed/evening primrose oils on the mammalian target of rapamycin complex 1 and interferon-gamma genes expression in experimental autoimmune encephalomyelitis
by: Soheila Rezapour-Firouzi, et al.
Published: (2018-01-01)

Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis
by: Nathalia Bernardes Teixeira, et al.
Published: (2020-09-01)

Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
by: Dariush Haghmorad, et al.
Published: (2022-11-01)

TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis
by: Mellanby Richard J, et al.
Published: (2012-10-01)

Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
by: Maria-Eleni Androutsou, et al.
Published: (2020-10-01)

Enhancing the efficacy of Hypericum perforatum in the treatment of an experimental model of multiple sclerosis using gold nanoparticles: an in vivo study
by: Mahmoud Mahmoudi, et al.
Published: (2022-05-01)

Generation of a murine model of chronic progressive Experimental Autoimmune Encephalomyelitis for molecular pharmacology studies in Multiple Sclerosis
by: Karelia Macías-Cosme, et al.

Allopregnanolone and Neuroinflammation: a Focus on Multiple Sclerosis
by: Farshid eNoorbakhsh, et al.
Published: (2014-06-01)

Toward a Combination of Biomarkers for Molecular Characterization of Multiple Sclerosis
by: Dafni Birmpili, et al.
Published: (2022-11-01)

Response Surface Methodology Approach to Optimize the Expression of Thioredoxin-MOG Fusion Protein
by: Maryam Radmard, et al.
Published: (2024-04-01)

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
by: Judith Derdelinckx, et al.
Published: (2021-02-01)

Nature plus Nurture*: the triggering of multiple sclerosis
by: Hartmut Wekerle
Published: (2015-09-01)

The Anti-inflammatory Effect of Ginger Extract on the Animal Model of Multiple Sclerosis
by: Fatemeh Kamankesh, et al.
Published: (2023-06-01)

Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
by: Sundararajan Jayaraman, et al.
Published: (2022-10-01)

A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis
by: Euan R. O. Allan, et al.
Published: (2017-05-01)

The Role of Selected Interleukins in the Development and Progression of Multiple Sclerosis—A Systematic Review
by: Cezary Grunwald, et al.
Published: (2024-02-01)

Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis
by: Petra Hundehege, et al.
Published: (2018-11-01)

Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels
by: Gareth Pryce, et al.
Published: (2023-07-01)

Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice
by: Saad MA, et al.
Published: (2022-09-01)

Targeted Expression of Myelin Autoantigen in the Periphery Induces Antigen-Specific T and B Cell Tolerance and Ameliorates Autoimmune Disease
by: Shin-Young Na, et al.
Published: (2021-06-01)

Curcumin ameliorates oxidative stress in animal models of multiple sclerosis
by: Laleh Mavaddatiyan, et al.
Published: (2019-04-01)

A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion
by: Florent Salvador, et al.
Published: (2022-02-01)

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis
by: Jordan R. Warford, et al.
Published: (2018-01-01)

Effects of Quercetin on Improving the Damage Caused by Free Radicals in the Rat Models of Multiple Sclerosis
by: Elina Mirzazadeh, et al.
Published: (2019-04-01)

B cells in multiple sclerosis
by: Hartmut Wekerle
Published: (2017-01-01)

Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8+ T cells derived from autoantigen-deficient mice.
by: Melanie D Leech, et al.
Published: (2011-05-01)

The Effects of Nicotine on the Stimulation of the Cholinergic System and Immune Responses Changes in Animal Models of Multiple Sclerosis
by: M Shahmoradi, et al.
Published: (2016-06-01)

Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis
by: Lisa Thiele née Schrewe, et al.
Published: (2020-01-01)

Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
by: Juliana Helena dos Santos de Toledo, et al.
Published: (2020-10-01)

Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model
by: Shan-Shan Zhong, et al.
Published: (2017-01-01)

Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy
by: Jacqueline M. Orian, et al.
Published: (2021-02-01)

Direct modulation of myelin-autoreactive CD4+ and CD8+ T cells in EAE mice by a tolerogenic nanoparticle co-carrying myelin peptide-loaded major histocompatibility complexes, CD47 and multiple regulatory molecules
by: Pei W, et al.
Published: (2018-06-01)

The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology
by: Roberta Amoriello, et al.
Published: (2024-01-01)

Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis
by: Antonietta eGentile, et al.
Published: (2015-06-01)